Neupogen — Medica
Cytokine Release Syndrome associated with Chimeric Antigen Receptor (CAR) T-cell therapy in patients with neutropenia
Initial criteria
- Prescribed for a patient who has neutropenia
Approval duration
1 month
Cytokine Release Syndrome associated with Chimeric Antigen Receptor (CAR) T-cell therapy in patients with neutropenia
1 month